TESARO Announces Clearance of Investigational New Drug Application for TSR-011
October 02, 2012 16:30 ET
|
TESARO, Inc.
WALTHAM, Mass., Oct. 2, 2012 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that the Investigational New Drug (IND) application for TSR-011, an orally available ALK inhibitor (targeted...
TESARO, Inc. Appoints Robert E. Martell, M.D., Ph.D. as Chief Medical Officer
September 04, 2012 16:56 ET
|
TESARO, Inc.
WALTHAM, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) today announced the appointment of Dr. Robert Martell as Chief Medical Officer. Dr. Martell is a practicing medical...
TESARO, Inc. to Present at the 2012 Morgan Stanley Global Healthcare Conference
September 04, 2012 15:52 ET
|
TESARO, Inc.
WALTHAM, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, Chief Executive Officer, and Mary Lynne Hedley, Ph.D., President and Chief Scientific...
TESARO, Inc. to Present at Upcoming Conferences
August 29, 2012 16:15 ET
|
TESARO, Inc.
WALTHAM, Mass., Aug. 29, 2012 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) today announced that Lonnie Moulder, Chief Executive Officer, will be presenting at the Robert W. Baird 2012 Healthcare...
TESARO Announces Second Quarter 2012 Operating Results
July 26, 2012 07:00 ET
|
TESARO, Inc.
Key Rolapitant Clinical Trial Results Presented at ASCO and MASCC Meetings
In-Licensed Niraparib, a Potentially First and Best-in-Class PARP Inhibitor
Raised Over $86.8 Million in Gross...
TESARO, Inc. Announces Exercise of Underwriters' Over-Allotment Option
July 24, 2012 17:00 ET
|
TESARO, Inc.
WALTHAM, Mass., July 24, 2012 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that the underwriters of its initial public offering have partially exercised their over-allotment option...
TESARO, Inc. to Announce Second Quarter 2012 Financial Results on Thursday, July 26th, 2012
July 19, 2012 07:00 ET
|
TESARO, Inc.
WALTHAM, Mass., July 19, 2012 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) will announce its second quarter 2012 financial results on Thursday, July 26th, 2012, before the open of the U.S. financial...
TESARO, Inc. Announces Pricing of Initial Public Offering
June 27, 2012 19:48 ET
|
TESARO, Inc.
WALTHAM, Mass., June 27, 2012 (GLOBE NEWSWIRE) -- TESARO, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock at a price to the public of $13.50 per...